Platelet-derived growth factor BB secreted from osteoclasts acts as an osteoblastogenesis inhibitory factor.
about
The biological function of type I receptors of bone morphogenetic protein in boneProteomics approaches for the studies of bone metabolismBone cell communication factors and SemaphorinsRANKL Is Necessary and Sufficient to Initiate Development of Antigen-Sampling M Cells in the Intestinal EpitheliumBone microstructure and regional distribution of osteoblast and osteoclast activity in the osteonecrotic femoral head.Osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor beta signalingFactors and mechanisms involved in the coupling from bone resorption to formation: how osteoclasts talk to osteoblasts.PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis.PDGF-AA promotes osteogenic differentiation and migration of mesenchymal stem cell by down-regulating PDGFRα and derepressing BMP-Smad1/5/8 signaling.Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesisPurification and identification of activating enzymes of CS-0777, a selective sphingosine 1-phosphate receptor 1 modulator, in erythrocytesPTEN regulates PDGF ligand switch for β-PDGFR signaling in prostate cancerA novel function for platelet-derived growth factor D: induction of osteoclastic differentiation for intraosseous tumor growthPI3K/AKT pathway involvement in the osteogenic effects of osteoclast culture supernatants on preosteoblast cells.Mechanisms of osteoclast-dependent bone formation.Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unitLymphangiogenesis, myeloid cells and inflammation.Osteoclast-derived coupling factors in bone remodeling.Identification of early vascular calcification with (18)F-sodium fluoride: potential clinical application.The effect of the dual PI3K and mTOR inhibitor BEZ235 on tumour growth and osteolytic bone disease in multiple myeloma.VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism.Bone-metastatic potential of human prostate cancer cells correlates with Akt/PKB activation by alpha platelet-derived growth factor receptor.Effect of sustained gene delivery of platelet-derived growth factor or its antagonist (PDGF-1308) on tissue-engineered cementum.Identification of 2'-phosphodiesterase, which plays a role in the 2-5A system regulated by interferon.Effect of sustained PDGF nonviral gene delivery on repair of tooth-supporting bone defectsSTAT1 modulates tissue wasting or overgrowth downstream from PDGFRβ.The regulatory landscape of osteogenic differentiation.BMP Signaling Mediated by BMPR1A in Osteoclasts Negatively Regulates Osteoblast Mineralization Through Suppression of Cx43.Abnormal subchondral bone microstructure following steroid administration is involved in the early pathogenesis of steroid-induced osteonecrosis.Platelet-derived growth factor-BB attenuates titanium-particle-induced osteolysis in vivo.Effect of platelet-derived growth factor-BB on root resorption after reimplantation of partially denuded tooth in dog.The Role of Extracellular Vesicles in Bone Metastasis.
P2860
Q26752839-2250BA4D-8860-4AC6-B90C-E2CA4664F131Q27016578-C1BFEA15-C27B-4C31-9D62-307AEA012AF9Q27023494-F90E0D13-C885-4CC3-BE01-D2C923E36ECDQ29397534-97C627A7-4D2C-4A7D-926C-AA6BF672543BQ31160503-65A6FC08-BC9D-44DB-90F8-1A1E23929398Q33379619-386CBB91-F94C-4EE8-B8C8-8180F2A9F64AQ34219161-606A8D15-2CC4-410D-BCD4-040798EB9B77Q34474147-E0022AA5-8876-4ECE-B582-09B40DC34081Q34627291-4F9537A2-6902-4101-8A0A-95110BDCE983Q35029178-D37406C0-CB9C-437F-AC24-886BCD9930E2Q35107430-69168D7A-D26E-4F90-A48C-2DBDB656A2BCQ35952035-C59DB951-AC82-467F-985D-096780148955Q36352562-D9CF0F1A-93B2-43A4-8EBE-695D26C0E357Q37143068-1632986C-315E-4CC2-9226-01FCD26EEB43Q37414413-2808C57A-CA53-40D5-AFEA-BA5EC2BD5314Q37506724-02D5006B-20E7-4F50-89F1-600546D2D350Q37754580-E4AB5076-4F0C-4F67-A3BA-7619507589DCQ38108750-1B4EC424-0A67-4D8E-B3D1-25BCCF1A8582Q38725762-8E7D68B6-D9E9-4CEB-80E6-38342DAB384DQ38960721-7F423BB4-6C5B-43B7-93EE-255E0FD3FD91Q39647223-AD3D1BE1-9429-45DA-9511-D1772C9935B6Q40399499-D888874C-008E-4D0A-BFF7-99A68D2D8889Q40565977-2EF27A3E-4FB9-41C9-8172-73FD4EFE94B4Q41412996-B7BB94B2-C225-400E-865B-2175B66346C5Q42327817-7A66ADC5-A255-44AA-AF40-390720241786Q42797555-867DBCD4-AD92-4D21-97A9-3C9B2DEB0E8DQ43660854-16EB8CCD-2E16-4AF6-8B5B-543CF2B845C7Q46276784-8156E7A3-81E1-49D4-87A5-ABA6927BE177Q51008001-E9BBD089-AB51-44ED-AE0D-AB45CC3E8AE7Q51366003-B9BEC763-AC0A-4D49-87CA-971F625FBB63Q51393339-C3966E24-F9C3-40D6-8F2C-5A828943F56AQ52324737-1DB3BABC-9F39-4983-83F6-5E850112087B
P2860
Platelet-derived growth factor BB secreted from osteoclasts acts as an osteoblastogenesis inhibitory factor.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Platelet-derived growth factor ...... astogenesis inhibitory factor.
@en
type
label
Platelet-derived growth factor ...... astogenesis inhibitory factor.
@en
prefLabel
Platelet-derived growth factor ...... astogenesis inhibitory factor.
@en
P2093
P1476
Platelet-derived growth factor ...... astogenesis inhibitory factor.
@en
P2093
Chisa Sakikawa
Kazuishi Kubota
Kenji Wakabayashi
Mutsumi Katsumata
Takemichi Nakamura
P304
P356
10.1359/JBMR.2002.17.2.257
P577
2002-02-01T00:00:00Z